Exendin-4 acetate is primarily used in the management of type 2 diabetes. It functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels. This medication is administered via injection and works by stimulating insulin secretion in response to meals, suppressing glucagon release, and slowing gastric emptying. These actions collectively contribute to better glycemic control. Additionally, it has been associated with weight loss in some patients, making it a beneficial option for those who are overweight or obese. Exendin-4 acetate is often prescribed when other diabetes medications have not provided adequate control, and it can be used alone or in combination with other antidiabetic agents. Regular monitoring of blood sugar levels is essential while using this medication to ensure optimal therapeutic outcomes.